Tag: vaccine trial

Washington: Pfizer Inc and partner BioNTech SE's COVID-19 vaccine candidate produced no severe allergic reactions during clinical trials, a Pfizer executive said at a regulatory conference on Friday. According to ...

New Delhi: Johnson & Johnson’s COVID-19 vaccine candidate’s late-stage study was paused as the company probes into a participant’s “unexplained illness”. In a statement on Monday, the company said that ...

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I clinical trials in India. Covaxin, which is developed by Bharat ...